Intra-Cellular Therapies ... (ITCI)
NASDAQ: ITCI
· Real-Time Price · USD
131.87
0.00 (0.00%)
At close: Apr 01, 2025, 3:59 PM
Intra-Cellular Therapies Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 306.95M | 464.31M | 695.06M | 141.57M | 147.77M | 99.4M | 142.26M | 75.73M | 148.62M | 135.36M | 77.23M | 129.29M | 92.36M | 106.13M | 121.03M | 129.98M |
Short-Term Investments | 694.12M | 542.25M | 329.6M | 335.8M | 350.17M | 393.62M | 370.6M | 462.98M | 443.29M | 493.38M | 600.59M | 642.55M | 319.97M | 371.16M | 433.73M | 481.98M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 44.65M | 36.7M | 40.3M | 42.51M | 45.91M | 86K | 86K | 86K | 86K | 86K | 86K | 86K | 86.08K | 86.08K | 86.08K | 86.08K |
Receivables | 166.5M | 145.61M | 145.71M | 131.16M | 114.02M | 102.67M | 95.96M | 81.55M | 75.19M | 61.54M | 46.98M | 32.83M | 20.16M | 16.93M | 15.19M | 13.66M |
Inventory | 26.28M | 23.54M | 20.08M | 15.95M | 11.65M | 42.99M | 41.9M | 28.34M | 23.92M | 23.6M | 25.02M | 7.89M | 7.95M | 8.17M | 7.77M | 7.58M |
Other Current Assets | 113.52M | 96.02M | 75.55M | 17.95M | 44.19M | 63.75M | 47.36M | 57.5M | 46.94M | 21.55M | 16.4M | 18.4M | 10.9M | 10.9M | 6M | 4.4M |
Total Current Assets | 1.31B | 1.27B | 1.26B | 690.53M | 667.8M | 702.42M | 698.07M | 706.09M | 737.96M | 759.76M | 789.21M | 848.34M | 467.28M | 533.24M | 601.3M | 649.1M |
Property-Plant & Equipment | 14.9M | 16.02M | 15.95M | 14M | 14.58M | 15.15M | 15.44M | 15.98M | 16.74M | 22.16M | 22.61M | 20.15M | 22.56M | 23.65M | 24.31M | 25.3M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 59.55M | 52.71M | 56.25M | 56.51M | 60.5M | 15.24M | 15.53M | 16.06M | 16.82M | 22.24M | 22.7M | 20.24M | 22.64M | 23.73M | 24.39M | 25.39M |
Total Assets | 1.37B | 1.32B | 1.32B | 747.04M | 728.29M | 717.66M | 713.6M | 722.16M | 754.78M | 782M | 811.91M | 868.58M | 489.92M | 556.98M | 625.7M | 674.49M |
Account Payables | 26.07M | 10.34M | 17.55M | 11.53M | 11.45M | 10.61M | 7.73M | 8.44M | 10.39M | 14.22M | 10.75M | 11.65M | 8.69M | 12.03M | 15.94M | 8.72M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 25.04M | n/a |
Short-Term Debt | n/a | 4.2M | 4.17M | n/a | 3.61M | 3.58M | 3.56M | 3.53M | n/a | 7.25M | 7.74M | 7.64M | n/a | n/a | n/a | n/a |
Other Current Liabilities | 34.77M | 117.87M | 113.51M | n/a | 77.5M | 59.86M | 55.61M | 47.43M | n/a | 27.55M | 26.01M | 15.51M | -522 | n/a | n/a | n/a |
Total Current Liabilities | 205.7M | 166.11M | 161.78M | 134.8M | 123.55M | 103.09M | 92.08M | 79.59M | 83.24M | 77.41M | 70.63M | 59.07M | 53.36M | 49.9M | 50.42M | 39.7M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 18.67B | n/a | n/a | 22.64B |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -18.67B | n/a | n/a | -22.64B |
Total Long-Term Liabilities | 12.75M | 13.51M | 14.12M | 12.74M | 13.33M | 13.89M | 14.43M | 14.96M | 15.47M | 19.17M | 19.07M | 16.76M | 18.67M | 20.32M | 21.69M | 22.64M |
Total Liabilities | 218.45M | 179.62M | 175.89M | 147.54M | 136.87M | 116.98M | 106.51M | 94.55M | 98.71M | 96.58M | 89.71M | 75.83M | 72.03M | 70.22M | 72.11M | 62.34M |
Total Debt | 16.98M | 17.71M | 18.29M | 16.38M | 16.94M | 17.48M | 17.99M | 18.49M | 20.04M | 26.41M | 26.82M | 24.39M | 25.41M | 26.41M | 27.28M | 28.21M |
Common Stock | 11K | 11K | 11K | 10K | 10K | 10K | 10K | 10K | 9K | 9K | 9K | 9K | 8.19K | 8.14K | 8.13K | 8.11K |
Retained Earnings | -1.69B | -1.67B | -1.65B | -1.63B | -1.62B | -1.59B | -1.56B | -1.52B | -1.48B | -1.43B | -1.38B | -1.29B | -1.22B | -1.14B | -1.06B | -989.84M |
Comprehensive Income | 191K | 1.63M | -668K | -430K | 104K | -1.33M | -2.27M | -2.7M | -4.19M | -5.5M | -4.8M | -3.33M | -363.65K | 94.2K | 176.12K | 246.54K |
Shareholders Equity | 1.15B | 1.14B | 1.14B | 599.5M | 591.42M | 600.68M | 607.09M | 627.61M | 656.07M | 685.42M | 722.2M | 792.75M | 417.89M | 486.76M | 553.59M | 612.15M |
Total Investments | 694.12M | 542.25M | 329.6M | 335.8M | 350.17M | 393.62M | 370.6M | 462.98M | 443.29M | 493.38M | 600.59M | 642.55M | 319.97M | 371.16M | 433.73M | 481.98M |